Pine Care Group Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Yip Keung Chan
Chief executive officer
HK$1.2m
Total compensation
| CEO salary percentage | 57.6% |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | no data |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
Some Investors May Be Worried About Pine Care Group's (HKG:1989) Returns On Capital
Apr 08
Pine Care Group (HKG:1989) Could Be Struggling To Allocate Capital
Sep 30Pine Care Group (HKG:1989) Might Be Having Difficulty Using Its Capital Effectively
Jun 05Estimating The Intrinsic Value Of Pine Care Group Limited (HKG:1989)
May 10If You Like EPS Growth Then Check Out Pine Care Group (HKG:1989) Before It's Too Late
Mar 21Is Pine Care Group (HKG:1989) Likely To Turn Things Around?
Mar 07Is Pine Care Group Limited's (HKG:1989) ROE Of 7.9% Impressive?
Feb 23Update: Pine Care Group (HKG:1989) Stock Gained 49% In The Last Three Years
Feb 10
Pine Care Group Limited (HKG:1989) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Jan 28What Kind Of Shareholders Hold The Majority In Pine Care Group Limited's (HKG:1989) Shares?
Jan 21Have Insiders Sold Pine Care Group Limited (HKG:1989) Shares Recently?
Dec 24I Ran A Stock Scan For Earnings Growth And Pine Care Group (HKG:1989) Passed With Ease
Dec 10Is Pine Care Group (HKG:1989) Likely To Turn Things Around?
Nov 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -HK$36m |
| Jun 30 2022 | n/a | n/a | -HK$28m |
| Mar 31 2022 | HK$1m | HK$720k | -HK$21m |
| Dec 31 2021 | n/a | n/a | -HK$13m |
| Sep 30 2021 | n/a | n/a | -HK$5m |
| Jun 30 2021 | n/a | n/a | HK$627k |
| Mar 31 2021 | HK$738k | HK$720k | HK$6m |
| Dec 31 2020 | n/a | n/a | HK$12m |
| Sep 30 2020 | n/a | n/a | HK$17m |
| Jun 30 2020 | n/a | n/a | HK$16m |
| Mar 31 2020 | HK$738k | HK$720k | HK$14m |
| Dec 31 2019 | n/a | n/a | HK$14m |
| Sep 30 2019 | n/a | n/a | HK$14m |
| Jun 30 2019 | n/a | n/a | HK$14m |
| Mar 31 2019 | HK$738k | HK$720k | HK$13m |
| Dec 31 2018 | n/a | n/a | HK$14m |
| Sep 30 2018 | n/a | n/a | HK$14m |
| Jun 30 2018 | n/a | n/a | HK$15m |
| Mar 31 2018 | HK$738k | HK$720k | HK$16m |
| Dec 31 2017 | n/a | n/a | HK$13m |
| Sep 30 2017 | n/a | n/a | HK$9m |
| Jun 30 2017 | n/a | n/a | HK$11m |
| Mar 31 2017 | HK$436k | HK$418k | HK$12m |
| Mar 31 2016 | HK$367k | HK$353k | HK$26m |
Compensation vs Market: Yip Keung's total compensation ($USD159.30K) is below average for companies of similar size in the Hong Kong market ($USD232.89K).
Compensation vs Earnings: Yip Keung's compensation has increased whilst the company is unprofitable.
CEO
Yip Keung Chan (38 yo)
2.3yrs
Tenure
HK$1,249,000
Compensation
Mr. Yip Keung Chan serves as Independent Non-Executive Director of OrbusNeich Medical Group Holdings Limited since September 29, 2021 and is primarily responsible for supervising and providing independent...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 6.8yrs | HK$1.25m | 0.098% HK$ 799.2k | |
| Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 2.9yrs | HK$115.00k | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 2.3yrs | HK$115.00k | no data | |
| Independent Non-Executive Director | 2.3yrs | HK$115.00k | no data | |
| Non-Executive Chairman | less than a year | no data | no data | |
| Independent Non-Executive Director | 2.3yrs | HK$115.00k | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Non-Executive Director | less than a year | no data | no data |
1.3yrs
Average Tenure
62.5yo
Average Age
Experienced Board: 1989's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.